A C 5 N 2 Nanoparticle Based Direct Nucleus Delivery Platform for Synergistic Cancer Therapy

2019 ◽  
Vol 131 (19) ◽  
pp. 6356-6360
Author(s):  
Weihua Chen ◽  
Jianhua Liu ◽  
Ying Wang ◽  
Chunhuan Jiang ◽  
Bin Yu ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Delivery Platform

scholarly journals Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy

2018 ◽  
Vol 9 ◽  
Author(s):  
Sangram Raut ◽  
Linda Mooberry ◽  
Nirupama Sabnis ◽  
Ashwini Garud ◽  
Akpedje Serena Dossou ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Cancer Therapy ◽  
Biological Barriers ◽  
Delivery Platform

scholarly journals Mono-arginine Cholesterol-based Small Lipid Nanoparticles as a Systemic siRNA Delivery Platform for Effective Cancer Therapy

Theranostics ◽  
2016 ◽  
Vol 6 (2) ◽  
pp. 192-203 ◽  
Author(s):  
Jinju Lee ◽  
Phei Er Saw ◽  
Vipul Gujrati ◽  
Yonghyun Lee ◽  
Hyungjun Kim ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Sirna Delivery ◽  
Lipid Nanoparticles ◽  
Delivery Platform ◽  
Effective Cancer Therapy

Graphene as multifunctional delivery platform in cancer therapy

2017 ◽  
Vol 105 (8) ◽  
pp. 2355-2367 ◽  
Author(s):  
Mojgan Nejabat ◽  
Fahimeh Charbgoo ◽  
Mohammad Ramezani
Keyword(s):  
Cancer Therapy ◽  
Delivery Platform

scholarly journals Amphiphilic irinotecan–melampomagnolide B conjugate nanoparticles for cancer chemotherapy

RSC Advances ◽  
2020 ◽  
Vol 10 (15) ◽  
pp. 8958-8966 ◽  
Author(s):  
Wenhao Qu ◽  
Quanjun Yang ◽  
Guanchun Wang ◽  
Zhaohong Wang ◽  
Ping Huang ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Cancer Chemotherapy ◽  
Delivery Platform

Ir–C–MMB nanoparticles can be easily fabricated using an ADDC strategy, and used as a MMB drug self-delivery platform for synergistic cancer therapy.

Precise delivery of a multifunctional nanosystem for MRI-guided cancer therapy and monitoring of tumor response by functional diffusion-weighted MRI

2019 ◽  
Vol 7 (18) ◽  
pp. 2926-2937 ◽  
Author(s):  
Zeyu Xiao ◽  
Leung Chan ◽  
Dong Zhang ◽  
Cuiqing Huang ◽  
Chaoming Mei ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Cancer Therapy ◽  
Mr Imaging ◽  
High Efficiency ◽  
Tumor Response ◽  
Diffusion Weighted Mri ◽  
Diffusion Weighted ◽  
Delivery Platform ◽  
Mri Guided ◽  
Cancer Theranostics

Herein we synthesize a cRGD peptide-conjugated PLGA nanosystem which is a high-efficiency drug-delivery platform for MR imaging-guided cancer theranostics.

Albumin coated trimethyl chitosan-based targeting delivery platform for photothermal/chemo-synergistic cancer therapy

2020 ◽  
Vol 241 ◽  
pp. 116335
Author(s):  
Haiyan Hu ◽  
Qi Qi ◽  
Ziyi Dong ◽  
Xianglong Yu ◽  
Yujia Mo ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Trimethyl Chitosan ◽  
Targeting Delivery ◽  
Delivery Platform

scholarly journals Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy

Pharmaceutics ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 520
Author(s):  
Tianqi Wang ◽  
Yusuke Suita ◽  
Saradha Miriyala ◽  
Jordan Dean ◽  
Nikos Tapinos ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Cancer Therapy ◽  
Cancer Treatment ◽  
Clinical Translation ◽  
Hybrid Nanoparticles ◽  
Future Perspectives ◽  
Preclinical Research ◽  
Delivery Platform

Nanomedicines have shown great potential in cancer therapy; in particular, the combination of chemotherapy and immunotherapy (namely chemoimmunotherapy) that is revolutionizing cancer treatment. Currently, most nanomedicines for chemoimmunotherapy are still in preclinical and clinical trials. Lipid-based nanoparticles, the most widely used nanomedicine platform in cancer therapy, is a promising delivery platform for chemoimmunotherapy. In this review, we introduce the commonly used immunotherapy agents and discuss the opportunities for chemoimmunotherapy mediated by lipid-based nanoparticles. We summarize the clinical trials involving lipid-based nanoparticles for chemoimmunotherapy. We also highlight different chemoimmunotherapy strategies based on lipid-based nanoparticles such as liposomes, nanodiscs, and lipid-based hybrid nanoparticles in preclinical research. Finally, we discuss the challenges that have hindered the clinical translation of lipid-based nanoparticles for chemoimmunotherapy, and their future perspectives.

Redox-Responsive Polyphosphate Nanosized Assemblies: A Smart Drug Delivery Platform for Cancer Therapy

2011 ◽  
Vol 12 (6) ◽  
pp. 2407-2415 ◽  
Author(s):  
Jinyao Liu ◽  
Yan Pang ◽  
Wei Huang ◽  
Zhaoyang Zhu ◽  
Xinyuan Zhu ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Cancer Therapy ◽  
Redox Responsive ◽  
Delivery Platform ◽  
Smart Drug ◽  
Smart Drug Delivery
Sign in / Sign up

Export Citation Format

Share Document